What the CRISPR Patent Decision Means for Gene Editing
The U.S. Patent Office has finally ruled on the century’s biggest biotech discovery.
The biotech trial of the century is over—for now. On Wednesday, the U.S. Patent and Trademark Office decided in favor of the Broad Institute, which has been battling the University of California for the patent over CRISPR, a widely hyped gene-editing technique with applications in human medicine, agriculture, and beyond.
The ruling lets
